Weave Bio

BiotechnologySeries ANew Haven, USweave.bio

Latest round

Series A

Last raised

Oct 2025

Total raised

$30M

Investors

6

About Weave Bio

Founded in 2022 by Ari Caroline, Brandon Rice, Umut Eser, based in San Francisco, US, Weave Bio provider of technology solutions to streamline paperwork processes for biotechnology and pharmaceutical industries, primarily through their AutoIND service. Weave Bio offers a suite of regulatory automation tools tailored for different stakeholders in the biotechnology and pharmaceutical industries. AutoIND: A module designed to streamline the preparation of Investigational New Drug (IND) applications by automating content generation and ensuring compliance with regulatory requirements. AutoCT: A tool to simplifying clinical trial submissions by organizing and structuring regulatory documents efficiently. AI-Assisted Review & Refinement: The platform allows users to generate drafts instantly, modify narratives, verify data sources, and refine content through AI-powered suggestions. Weave Bio earns revenue through its SaaS platform subscriptions and enterprise solutions tailored for biotech, pharma, and consulting firms. It also offers white-labeled collaborative platforms for CROs and consultants.4 million.

Who invested in Weave Bio

6 investors across 2 rounds

See all investors in Weave Bio

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Oct 16, 2025

    Amount

    $20M

    Investors

    Locked

  2. Seed

    May 30, 2024

    Amount

    $10M

    Investors

    Locked

Questions about Weave Bio

Who invested in Weave Bio?

Weave Bio has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Weave Bio raised?

Weave Bio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Weave Bio last raise money?

Weave Bio's most recent round on record is a Series A, in Oct 2025.

What does Weave Bio do?

Founded in 2022 by Ari Caroline, Brandon Rice, Umut Eser, based in San Francisco, US, Weave Bio provider of technology solutions to streamline paperwork processes for biotechnology and pharmaceutical industries, primarily through their AutoIND service.

Where is Weave Bio headquartered?

Weave Bio is headquartered in New Haven, US.

Which VCs invest in companies like Weave Bio?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Weave Bio's stage. Their profiles are linked below.

Raising like Weave Bio? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.